These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis. Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406 [TBL] [Abstract][Full Text] [Related]
3. Treatment of diffuse aggressive non-Hodgkin's lymphomas with an intensive multi-drug regimen including high-dose cytosine arabinoside (F-MACHOP). Amadori S; Guglielmi C; Anselmo AP; Cimino G; Ruco LP; Papa G; Biagini C; Mandelli F Semin Oncol; 1985 Jun; 12(2 Suppl 3):218-22. PubMed ID: 4012340 [No Abstract] [Full Text] [Related]
4. The use of high-dose cytosine arabinoside for non-Hodgkin's lymphoma. Richards MA; Barnett MJ; Waxman JH; Rohatiner AZ; Dhaliwal HS; Gallagher CJ; Lister TA Semin Oncol; 1985 Jun; 12(2 Suppl 3):223-6. PubMed ID: 4012341 [No Abstract] [Full Text] [Related]
5. Modified cyclophosphamide, vincristine, methotrexate, leucovorin, and cytarabine (COMLA) in intermediate- and high-grade lymphoma: an effective short-course regimen. Baer MR; Stein RS; Greer JP; Wolff SN; Hainsworth JD; Flexner JM Cancer Treat Rep; 1986 Jun; 70(6):785-7. PubMed ID: 3488125 [TBL] [Abstract][Full Text] [Related]
6. [Non-Hodgkin's lymphomas: recent achievements and therapeutic perspectives]. Bron D; Vandenheule B; Stryckmans P Rev Med Brux; 1985 Sep; 6(7):491-5. PubMed ID: 2417298 [No Abstract] [Full Text] [Related]
7. Increasing chemotherapy dose density and intensity: phase I trials in non-small cell lung cancer and non-Hodgkin's lymphoma. Blayney DW; McGuire BW; Cruickshank SE; Johnson DH Oncologist; 2005 Feb; 10(2):138-49. PubMed ID: 15709216 [TBL] [Abstract][Full Text] [Related]
8. ProMACE-CytaBOM: combination chemotherapy for diffuse large cell lymphoma. Prokocimer M; Modan M; Rusoshansky S; Bairey O; Shaklai M Anticancer Res; 1989; 9(4):1233-5. PubMed ID: 2479327 [TBL] [Abstract][Full Text] [Related]
9. [ABEP chemotherapy in the treatment of advanced non-Hodgkin's lymphomas]. Yoshida T; Nakanishi J; Ito K; Kobayashi K; Ohtake S; Nakamura S; Matsuda T; Nakagoshi T; Natori K; Nakamura E Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):984-9. PubMed ID: 3963862 [TBL] [Abstract][Full Text] [Related]
10. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. Fisher RI; Gaynor ER; Dahlberg S; Oken MM; Grogan TM; Mize EM; Glick JH; Coltman CA; Miller TP N Engl J Med; 1993 Apr; 328(14):1002-6. PubMed ID: 7680764 [TBL] [Abstract][Full Text] [Related]
11. Phase I/II trial of nonpegylated liposomal doxorubicin, cyclophosphamide, vincristine, and prednisone in the treatment of newly diagnosed aggressive non-Hodgkin's lymphoma. Tulpule A; Espina BM; Berman N; Buchanan LH; Smith DL; Sherrod A; Dharmapala D; Gee C; Boswell WD; Nathwani BN; Welles L; Levine AM Clin Lymphoma Myeloma; 2006 Jul; 7(1):59-64. PubMed ID: 16879771 [TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of non-Hodgkin's lymphoma patients treated with ProMACE-CytaBOM: an effective regimen for the intermediate grade subtype. Marotta G; Bigazzi C; Bocchia M; Forconi F; Lauria F Haematologica; 1998 Sep; 83(9):853-4. PubMed ID: 9825583 [TBL] [Abstract][Full Text] [Related]
13. [A comparative study of mitoxantrone and adriamycin in patients with non-Hodgkin's lymphoma: a preliminary result]. Kimura I; Ohnoshi T; Masaoka T; Sampi K; Namba K Gan To Kagaku Ryoho; 1986 Sep; 13(9):2813-9. PubMed ID: 3530138 [TBL] [Abstract][Full Text] [Related]
14. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group. Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V; J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249 [TBL] [Abstract][Full Text] [Related]
15. [Results of dose-intense, dose-impact weekly combination chemotherapy with rituximab for patients with CD 20-positive B-cell non-Hodgkin's lymphoma]. Uzuka Y; Saitou Y; Saitou K; Suzuki S; Yamaguchi M Gan To Kagaku Ryoho; 2007 Jul; 34(7):1085-90. PubMed ID: 17637545 [TBL] [Abstract][Full Text] [Related]
16. Pilot study of modified version of CHOP plus radiotherapy for early-stage aggressive non-Hodgkin's lymphoma of the head and neck. Nishioka T; Tsuchiya K; Nishioka S; Kitahara T; Ohmori K; Homma A; Aoyma H; Shindoh M; Shirato H Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):847-52. PubMed ID: 15465202 [TBL] [Abstract][Full Text] [Related]